The SARS-CoV-2, Influenza A+B, RSV, Adenovirus Antigen Detection Cartridge (nasopharyngeal) is a rapid immunochromatographic test for the simultaneous detection of SARS-CoV-2, Influenza A and B viruses, Respiratory Syncytial Virus (RSV) and Adenovirus. It aims to rapidly diagnose various respiratory viral infections in patients with respiratory symptoms such as fever, cough, sore throat and nasal congestion.

Sample: nasopharynx, nasal tract, oropharyngeal swab

Results in 10 minutes

Test accuracy, sensitivity, specificity

SARS-CoV-2: sensitivity 97,12 %; specificity 100%; precision 98,39%.

Influenza A: Sensitivity 96,60 %; specificity 100%; accuracy 99,30%.

Influenza B: sensitivity 97,22 %; specificity 100%; precision 98,83 %.

RSV: sensitivity 97,78 %; specificity 100%; precision 99,31 %.

ADV: sensitivity 100 %; specificity 99,13%; precision 99,34 %.

Back to top Drag